Drops nasal 0,05% (for children): transparent colourless liquid, inodorous (on 10 ml in polyethylene bottles with the cover dropper providing control of the first opening in a cardboard pack 1 bottle);
Drops nasal 0,1%: transparent liquid without color and a smell (on 10 ml in polyethylene bottles with the cover dropper providing control of the first opening in a cardboard pack 1 bottle);
Spray nasal dosed 0,05% (for children): transparent colourless solution, almost inodorous (on 10 ml in bottles from polyethylene of high density with the portioning device, in a cardboard pack 1 bottle complete with a protective cap and a tip);
Spray nasal dosed 0,1%: colourless transparent solution, almost inodorous (on 15 ml or 10 ml in polyethylene (high density) bottles with the portioning device, in a cardboard pack 1 bottle with a protective cap and a tip from polyethylene).

Active ingredient of Otrivinum – xylomethazolinum a hydrochloride:

1 ml of drops of 0,05% – 0,5 mg;
1 ml of drops of 0,1% – 1 mg;
1 ml of solution of 0,05% – 0,5 mg;
1 ml of solution of 0,1% – 1 mg.

Auxiliary components: gipromelloza 4000, hydrophosphate sodium dodecahydrate, dihydrophosphate sodium dihydrate, sodium chloride, dinatrium эдетат, sorbitol of 70%, benzalkoniya chloride (50% solution), water.

Indications to use

Rhinitis against the background of acute respiratory diseases;
Acute rhinitis of an allergic etiology;
Sinusitis;
Pollinosis;
Eustachitis;
Treatment of hypostasis of a nasopharynx at average otitis;
Training of the patient for diagnostic testings in the nasal courses.

Contraindications

Atrophic rhinitis;
Tachycardia;
Arterial hypertension;
Severe form of atherosclerosis;
Hyperthyroidism;
Glaucoma;
Existence in the anamnesis of surgeries on a meninx;
Hypersensitivity to drug components.

With care patients are recommended to apply Otrivinum with cardiovascular pathologies, a diabetes mellitus, hypersensitivity to the adrenergic means causing symptoms of dizziness, sleeplessness, arrhythmia, the increased arterial pressure (AP), a tremor.

Besides, spray of 0,1% and drops of 0,1% cannot be applied at children up to 6 years. With care it is necessary to appoint them at a prostate hyperplasia.

During pregnancy and breastfeeding it is necessary to use drug only on doctor's orders if the expected advantage of therapy for mother significantly exceeds potential threat for a fruit and the child, carefully observing the recommended doses.

Route of administration and dosage

Drops nasal 0,05% (for children)
Drops dig in in each nostril.

Dosing mode:

Children up to 6 years: on 1-2 drops 1-2 times a day, the maximum frequency rate of use should not exceed 3 times a day;
Children are more senior than 6 years: on 2-3 drops 3-4 times a day.

Duration of treatment is no more than 10 days.

Drops nasal 0,1%
Drops apply intranazalno, digging in in each nasal course.

The recommended dosing mode for patients is more senior than 6 years: on 2-3 drops 3-4 times a day, a course of treatment 3-4 days. In need of longer therapy it is necessary to get advice of the doctor.

Spray nasal dosed 0,05% (for children)
Spray is applied by injection of drug in each nostril.

Dosing mode:

Children up to 6 years: on 1 injection 1-2 times a day, but no more than 3 times a day;
Children are more senior than 6 years: on 2-3 injections 3-4 times a day.

Course of treatment no more than 10 days.

Spray nasal dosed 0,1%
Spray is injected into each nostril.

Drug is appointed to patients 6 years on 1 injection 3-4 times a day within 10 days are more senior.

Side effects

Local reactions: at long and/or frequent use – a pricking, burning, dryness and/or irritation of a mucous membrane of a nasopharynx, hypersecretion, sneezing; seldom – a rhinedema.

System reactions: at prolonged and/or frequent use – nausea; seldom – dizziness, vomiting, a headache, a heart consciousness, increase in the ABP, tachycardia, arrhythmia, a sight illegibility, sleeplessness, development of allergic reactions; at long therapy in high doses – a depression.

Special instructions

It is not necessary to break the recommended mode of dosing and the period of use of Otrivinum, especially at treatment of children and patients of advanced age.

At children till 1 year it is necessary to use drug only on doctor's orders.

To children under 6 years of the procedure of an instillation or injection adults have to make.

It is not necessary to apply drops of 0,1% more than 10 days.

Drug does not exert impact on ability of the patient to control of vehicles and mechanisms.